Quotient Sciences, the drug development and manufacturing accelerator, has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility. The expanded services build upon the site’s existing formulation capabilities and increases capacity to support fully integrated drug development programs through the company’s flagship platform, Translational Pharmaceuticals. With this latest investment, the company has expanded its ...